Your session is about to expire
← Back to Search
Physiotherapy and Deep Brain Stimulation for Parkinson's Disease
N/A
Waitlist Available
Led By Alfonso Fasano, MD, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1: baseline assessment at month 0, visit 2: pre-intervention assessment at month 3, visit 4: post-intervention assessment at month 6, and visit 5: end of study assessment at month 8
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether adding physical therapy to standard deep brain stimulation surgery helps improve mobility for people with Parkinson’s disease, beyond what surgery alone can achieve.
Who is the study for?
This trial is for adults over 18 with Parkinson's Disease who are candidates for Deep Brain Stimulation (DBS) surgery and can consent to participate. It excludes those already in physiotherapy, with orthopedic issues affecting mobility, or severe cognitive deficits (MoCA score <17).
What is being tested?
The study tests if combining DBS with physiotherapy improves independent mobility and reduces falls better than DBS alone in Parkinson's patients. The effectiveness of gait and balance training post-DBS will be evaluated.
What are the potential side effects?
While not explicitly stated, potential side effects may include typical risks associated with physiotherapy such as muscle soreness or fatigue, and those related to DBS like infection risk at the surgical site or changes in mood.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ visit 1: baseline assessment at month 0, visit 2: pre-intervention assessment at month 3, visit 4: post-intervention assessment at month 6, and visit 5: end of study assessment at month 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1: baseline assessment at month 0, visit 2: pre-intervention assessment at month 3, visit 4: post-intervention assessment at month 6, and visit 5: end of study assessment at month 8
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in mobility measures
Secondary study objectives
Anxiety
Balance
Balance confidence
+7 moreOther study objectives
Exploratory outcome - average number of steps
Exploratory outcome - distance
Exploratory outcome - heart rate
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Physiotherapy groupExperimental Treatment1 Intervention
Participants assigned to the physiotherapy group will receive physiotherapy treatment at One Step Ahead Mobility physiotherapy clinic for 1-hour per day, 3 times/week for 8 weeks. They will begin to receive the physiotherapy treatment at 4 months following their surgery and once their DBS settings are optimized.
Group II: Control groupActive Control1 Intervention
Participants assigned to the control group will not receive any additional intervention and will be precluded from starting formal physiotherapy for the duration of the study. However, they will be encouraged to keep an active lifestyle. In order to stay active, they will be recommended to do simple home exercises following a home exercise video that will be presented to them. They will be asked to do it 3 times/week for 8 weeks and keep an exercise log to help them stay on track.
Find a Location
Who is running the clinical trial?
University of TorontoLead Sponsor
714 Previous Clinical Trials
1,022,762 Total Patients Enrolled
Alfonso Fasano, MD, PhDPrincipal InvestigatorUniversity of Toronto
3 Previous Clinical Trials
68 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Physiotherapy group
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger